BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37230284)

  • 1. The emerging role of fatty acid binding protein 5 (FABP5) in cancers.
    George Warren W; Osborn M; Yates A; Wright K; O'Sullivan SE
    Drug Discov Today; 2023 Jul; 28(7):103628. PubMed ID: 37230284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FABP5 is correlated with poor prognosis and promotes tumour cell growth and metastasis in clear cell renal cell carcinoma.
    Wu G; Xu Y; Wang Q; Li J; Li L; Han C; Xia Q
    Eur J Pharmacol; 2019 Nov; 862():172637. PubMed ID: 31491402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty acid-binding protein 5 (FABP5) promotes lipolysis of lipid droplets, de novo fatty acid (FA) synthesis and activation of nuclear factor-kappa B (NF-κB) signaling in cancer cells.
    Senga S; Kobayashi N; Kawaguchi K; Ando A; Fujii H
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):1057-1067. PubMed ID: 29906613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty acid binding protein 5 regulates lipogenesis and tumor growth in lung adenocarcinoma.
    Garcia KA; Costa ML; Lacunza E; Martinez ME; Corsico B; Scaglia N
    Life Sci; 2022 Jul; 301():120621. PubMed ID: 35545133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer cells through enhancing epidermal growth factor receptor stability.
    Powell CA; Nasser MW; Zhao H; Wochna JC; Zhang X; Shapiro C; Shilo K; Ganju RK
    Oncotarget; 2015 Mar; 6(8):6373-85. PubMed ID: 25779666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K/AKT signaling pathway.
    Lv Q; Wang G; Zhang Y; Han X; Li H; Le W; Zhang M; Ma C; Wang P; Ding Q
    Int J Oncol; 2019 Apr; 54(4):1221-1232. PubMed ID: 30968158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cancer-promoting gene fatty acid-binding protein 5 (FABP5) is epigenetically regulated during human prostate carcinogenesis.
    Kawaguchi K; Kinameri A; Suzuki S; Senga S; Ke Y; Fujii H
    Biochem J; 2016 Feb; 473(4):449-61. PubMed ID: 26614767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acid activated PPARγ promotes tumorigenicity of prostate cancer cells by up regulating VEGF via PPAR responsive elements of the promoter.
    Forootan FS; Forootan SS; Gou X; Yang J; Liu B; Chen D; Al Fayi MS; Al-Jameel W; Rudland PS; Hussain SA; Ke Y
    Oncotarget; 2016 Feb; 7(8):9322-39. PubMed ID: 26814431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FABP5 coordinates lipid signaling that promotes prostate cancer metastasis.
    Carbonetti G; Wilpshaar T; Kroonen J; Studholme K; Converso C; d'Oelsnitz S; Kaczocha M
    Sci Rep; 2019 Dec; 9(1):18944. PubMed ID: 31831821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acid-binding protein 5 function in hepatocellular carcinoma through induction of epithelial-mesenchymal transition.
    Ohata T; Yokoo H; Kamiyama T; Fukai M; Aiyama T; Hatanaka Y; Hatanaka K; Wakayama K; Orimo T; Kakisaka T; Kobayashi N; Matsuno Y; Taketomi A
    Cancer Med; 2017 May; 6(5):1049-1061. PubMed ID: 28374947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty-acid-binding protein inhibition produces analgesic effects through peripheral and central mechanisms.
    Peng X; Studholme K; Kanjiya MP; Luk J; Bogdan D; Elmes MW; Carbonetti G; Tong S; Gary Teng YH; Rizzo RC; Li H; Deutsch DG; Ojima I; Rebecchi MJ; Puopolo M; Kaczocha M
    Mol Pain; 2017 Jan; 13():1744806917697007. PubMed ID: 28326944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acid-binding protein 5 limits the anti-inflammatory response in murine macrophages.
    Moore SM; Holt VV; Malpass LR; Hines IN; Wheeler MD
    Mol Immunol; 2015 Oct; 67(2 Pt B):265-75. PubMed ID: 26105806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signaling.
    Farrell M; Fairfield H; Karam M; D'Amico A; Murphy CS; Falank C; Pistofidi RS; Cao A; Marinac CR; Dragon JA; McGuinness L; Gartner CG; Iorio RD; Jachimowicz E; DeMambro V; Vary C; Reagan MR
    Elife; 2023 Mar; 12():. PubMed ID: 36880649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinoma.
    Pan L; Xiao H; Liao R; Chen Q; Peng C; Zhang Y; Mu T; Wu Z
    Biomed Pharmacother; 2018 Oct; 106():68-76. PubMed ID: 29957468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of adipocyte-derived lipids and enhanced intracellular trafficking of fatty acids contribute to breast cancer progression.
    Yang D; Li Y; Xing L; Tan Y; Sun J; Zeng B; Xiang T; Tan J; Ren G; Wang Y
    Cell Commun Signal; 2018 Jun; 16(1):32. PubMed ID: 29914512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty-acid-induced FABP5/HIF-1 reprograms lipid metabolism and enhances the proliferation of liver cancer cells.
    Seo J; Jeong DW; Park JW; Lee KW; Fukuda J; Chun YS
    Commun Biol; 2020 Oct; 3(1):638. PubMed ID: 33128030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of FABP5 expression with poor survival in triple-negative breast cancer: implication for retinoic acid therapy.
    Liu RZ; Graham K; Glubrecht DD; Germain DR; Mackey JR; Godbout R
    Am J Pathol; 2011 Mar; 178(3):997-1008. PubMed ID: 21356353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid-binding protein 5 controls microsomal prostaglandin E synthase 1 (mPGES-1) induction during inflammation.
    Bogdan D; Falcone J; Kanjiya MP; Park SH; Carbonetti G; Studholme K; Gomez M; Lu Y; Elmes MW; Smietalo N; Yan S; Ojima I; Puopolo M; Kaczocha M
    J Biol Chem; 2018 Apr; 293(14):5295-5306. PubMed ID: 29440395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant DNA methylation-mediated NF-κB/fatty acid-binding protein 5 (FABP5) feed-forward loop promotes malignancy of colorectal cancer cells.
    Kawaguchi K; Ohashi T; Kobayashi N; Kanemoto K; Nose M; Shinozaki R; Kataoka T; Fujii H
    Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Sep; 1868(9):159362. PubMed ID: 37414211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT5A reprograms fatty acid metabolism and promotes tumorigenesis of gastric cancer cells.
    Dong SR; Ju XL; Yang WZ
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8360-8370. PubMed ID: 31646566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.